New Britain General Hospital

New Britain, Connecticut 06052

0 studies enrolling now · 13 studies all time

What they study most

Anxiety Disorder, Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer, Endometrial Cancer, Infection, Leukemia, Lumbar Spinal Stenosis, Lymphoma, Major Depressive Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes

Studies at this site

• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• CATIE- Schizophrenia Trial — Completed
• Experimental Medication For the Treatment of Generalized Anxiety Disorder — Completed
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma — Completed
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer — Completed
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed
• Dynamic Stabilization for Lumbar Spinal Stenosis With Stabilimax NZ® Dynamic Spine Stabilization System — Stopped early
• Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer — Status unconfirmed